Skip to main content
. Author manuscript; available in PMC: 2020 Nov 1.
Published in final edited form as: Clin Lymphoma Myeloma Leuk. 2019 Jun 26;19(11):699–708.e5. doi: 10.1016/j.clml.2019.06.009

Table 3.

Multivariable Cox Regression Models of Predictors of Mortality in Patients With DLBCL and FL

Factors DLBCL (n = 7701; 20.0%)
FL (n = 4183; 10.9%)
HR 95% CI HR 95% CI
Age, y
  18–60 1.00 1.00
  >60 2.09 1.89–2.31 3.24 2.64–3.97
Gender
  Female 1.00 1.00
  Male 1.13 1.03–1.24 1.15 0.97,1.36
Race
  White 1.00 1.00
  Black 1.20 1.07–1.34 1.13 0.87–1.46
  Other 0.79 0.54–1.14 0.17 0.02–1.21
Disease stage
  I/II 1.00 1.00
  III/IV 1.61 1.45–1.78 1.22 1.02–1.45
Extranodal primary site
  No 1.00 1.00
  Yes 1.17 1.06–1.28 1.08 0.86–1.38
B symptoms
  No 1.00 1.00
  Yes 1.17 1.06–1.28 1.50 1.24–1.81

The multivariable model included each of the variables in the table: age, gender, race, disease stage, extranodal site of disease, and B-symptoms.

Abbreviations: CI = confidence interval; DLBCL = diffuse large B-cell lymphoma; FL = follicular lymphoma; HR = hazard ratio.